RxDoctor Payments Data

Joseph Kernich

Family Medicine · Punxsutawney, PANPI 1174518237

Payments from drug & device makers

$1,807in general payments, 2019–2025

Across 99 payments — averaging $18.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$430
  • Novo Nordisk$284
  • Boehringer Ingelheim$221
  • Pfizer$165
  • AstraZeneca$154
  • Novartis$148
  • plus $407 from 12 others

What the payments were for

  • Food & beverage$1,78899%
  • Education$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,807 in reported general payments places this provider in the 75th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban103$70,576
JardianceEmpagliflozin54$61,628
JanumetSitagliptin Phos/Metformin Hcl23$28,456
GlyxambiEmpagliflozin/Linagliptin34$23,844
MyrbetriqMirabegron40$18,369
FarxigaDapagliflozin Propanediol19$16,037
TradjentaLinagliptin18$15,985
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$13,458
XareltoRivaroxaban15$11,349
OzempicSemaglutide12$10,706
Breo ElliptaFluticasone/Vilanterol22$8,540
EntrestoSacubitril/Valsartan11$8,179
Tamsulosin Hcl249$6,389
Tresiba Flextouch U-200Insulin Degludec14$6,048
LinzessLinaclotide12$5,885

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Glyxambi, Tradjenta$221$101,457106 claims
PfizerEliquis$165$70,576103 claims
MerckJanumet$30$28,45623 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$32$27,31651 claims
AstraZenecaFarxiga$154$16,03719 claims
Johnson & JohnsonXarelto$430$11,34915 claims
Novo NordiskOzempic$284$10,70612 claims
AbbVieLinzess, Synthroid$36$9,54773 claims
NovartisEntresto$148$8,17911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Punxsutawney

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →